# Spruce Biosciences, Inc.: filings

SPRB · Nasdaq · CIK 1683553 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sprb.md) · [Financials](/companies/sprb/financials.md) · [Filings](/companies/sprb/filings.md) · [Insiders](/companies/sprb/insiders.md)

## Reports and events: 115 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 111, 8-K 63, 3 24, 10-Q 18, SC 13G/A 16, SCHEDULE 13G/A 14, SC 13D/A 13, SCHEDULE 13G 12, SC 13G 10, DEFA14A 9, CORRESP 8, S-8 8, 10-K 6, DEF 14A 6, EFFECT 5, 424B5 4, ARS 4, S-3 4, SC 13D 4, D 3, SCHEDULE 13D/A 3, UPLOAD 3, 144 2, SEC STAFF LETTER 2, 424B3 1, 424B4 1, 4/A 1, 8-A12B 1, CERT 1, D/A 1, DRS 1, NT 10-K 1, PRE 14A 1, S-1 1, S-1/A 1, S-1MEF 1, S-3/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-12 | 09:10 ET | [10-Q](/filings/0001193125-26-345876.md) | Quarterly report, period 2026-06-30 | 0001193125-26-345876 |
| 2026-08-12 | 09:05 ET | [8-K](/filings/0001193125-26-345874.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-345874 |
| 2026-07-27 | 08:05 ET | [8-K](/filings/0001193125-26-316928.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-316928 |
| 2026-05-26 | 16:02 ET | [8-K](/filings/0001193125-26-239230.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-239230 |
| 2026-05-13 | 16:06 ET | [10-Q](/filings/0001193125-26-221605.md) | Quarterly report, period 2026-03-31 | 0001193125-26-221605 |
| 2026-05-13 | 08:05 ET | [8-K](/filings/0001193125-26-220648.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-220648 |
| 2026-04-22 | 17:50 ET | [8-K](/filings/0001193125-26-167332.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-167332 |
| 2026-04-09 | 17:02 ET | [DEF 14A](/filings/0001193125-26-149821.md) | Proxy statement, period 2026-04-09 | 0001193125-26-149821 |
| 2026-03-20 | 17:04 ET | [8-K](/filings/0001193125-26-117888.md) | 1.02 Termination of a material agreement | 0001193125-26-117888 |
| 2026-03-09 | 07:23 ET | [8-K](/filings/0001193125-26-097561.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-097561 |
| 2026-03-09 | 07:21 ET | [10-K](/filings/0001193125-26-097558.md) | Annual report, period 2025-12-31 | 0001193125-26-097558 |
| 2026-02-18 | 22:27 ET | [SCHEDULE 13D/A](/filings/0001493152-26-007364.md) | Ownership report, active investor, amended | 0001493152-26-007364 |
| 2026-02-05 | 16:11 ET | [8-K](/filings/0001193125-26-039399.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-039399 |
| 2026-01-08 | 08:05 ET | [8-K](/filings/0001193125-26-007038.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-007038 |
| 2025-12-15 | 08:05 ET | [8-K](/filings/0001193125-25-318488.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-318488 |
| 2025-12-12 | 16:03 ET | [8-K](/filings/0001193125-25-317532.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-317532 |
| 2025-11-10 | 16:10 ET | [10-Q](/filings/0001193125-25-274234.md) | Quarterly report, period 2025-09-30 | 0001193125-25-274234 |
| 2025-11-10 | 16:07 ET | [8-K](/filings/0001193125-25-274216.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-274216 |
| 2025-10-17 | 16:05 ET | [8-K](/filings/0001193125-25-242488.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-242488 |
| 2025-10-09 | 17:33 ET | [SCHEDULE 13D/A](/filings/0001012975-25-000624.md) | Ownership report, active investor, amended | 0001012975-25-000624 |
| 2025-10-08 | 16:07 ET | [8-K](/filings/0001193125-25-234516.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-234516 |
| 2025-08-14 | 16:15 ET | [10-Q](/filings/0000950170-25-108888.md) | Quarterly report, period 2025-06-30 | 0000950170-25-108888 |
| 2025-08-14 | 16:10 ET | [8-K](/filings/0000950170-25-108868.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-108868 |
| 2025-07-24 | 16:12 ET | [8-K](/filings/0000950170-25-098340.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-098340 |
| 2025-06-12 | 08:10 ET | [8-K](/filings/0000950170-25-085144.md) | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-085144 |
| 2025-05-29 | 07:00 ET | [8-K](/filings/0000950170-25-078590.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.08 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-078590 |
| 2025-05-06 | 16:10 ET | [10-Q](/filings/0000950170-25-064463.md) | Quarterly report, period 2025-03-31 | 0000950170-25-064463 |
| 2025-05-06 | 16:05 ET | [8-K](/filings/0000950170-25-064429.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-064429 |
| 2025-04-28 | 16:05 ET | [DEF 14A](/filings/0000950170-25-059288.md) | Proxy statement, period 2025-06-09 | 0000950170-25-059288 |
| 2025-04-25 | 17:15 ET | [8-K](/filings/0000950170-25-058863.md) | 2.05 Exit or disposal costs; 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0000950170-25-058863 |
| 2025-04-15 | 07:15 ET | [10-K](/filings/0000950170-25-053945.md) | Annual report, period 2024-12-31 | 0000950170-25-053945 |
| 2025-04-15 | 07:05 ET | [8-K](/filings/0000950170-25-053944.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-053944 |
| 2025-04-01 | 17:15 ET | [8-K](/filings/0000950170-25-048726.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-048726 |
| 2025-01-10 | 11:05 ET | [SCHEDULE 13D/A](/filings/0001104659-25-002369.md) | Ownership report, active investor, amended | 0001104659-25-002369 |
| 2024-12-27 | 17:15 ET | [8-K](/filings/0000950170-24-140833.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-140833 |
| 2024-12-10 | 16:08 ET | [8-K](/filings/0000950170-24-134969.md) | 8.01 Other events | 0000950170-24-134969 |
| 2024-11-12 | 06:10 ET | [10-Q](/filings/0000950170-24-124479.md) | Quarterly report, period 2024-09-30 | 0000950170-24-124479 |
| 2024-11-12 | 06:02 ET | [8-K](/filings/0000950170-24-124436.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-124436 |
| 2024-10-28 | 17:15 ET | [8-K](/filings/0000950170-24-117786.md) | 3.01 Delisting notice | 0000950170-24-117786 |
| 2024-08-12 | 16:18 ET | [10-Q](/filings/0000950170-24-095461.md) | Quarterly report, period 2024-06-30 | 0000950170-24-095461 |
| 2024-08-12 | 16:09 ET | [8-K](/filings/0000950170-24-095417.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-095417 |
| 2024-06-18 | 17:00 ET | [8-K](/filings/0000950170-24-074990.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-074990 |
| 2024-06-03 | 07:05 ET | [8-K](/filings/0000950170-24-067650.md) | 8.01 Other events | 0000950170-24-067650 |
| 2024-05-24 | 16:05 ET | [8-K](/filings/0000950170-24-064561.md) | 5.07 Shareholder vote results | 0000950170-24-064561 |
| 2024-05-13 | 16:09 ET | [10-Q](/filings/0000950170-24-058657.md) | Quarterly report, period 2024-03-31 | 0000950170-24-058657 |
| 2024-05-13 | 16:05 ET | [8-K](/filings/0000950170-24-058635.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-058635 |
| 2024-04-30 | 17:00 ET | [8-K](/filings/0000950170-24-050612.md) | 3.01 Delisting notice | 0000950170-24-050612 |
| 2024-04-05 | 16:12 ET | [DEF 14A](/filings/0000950170-24-042270.md) | Proxy statement, period 2024-05-22 | 0000950170-24-042270 |
| 2024-03-28 | 21:15 ET | [SC 13D/A](/filings/0001193125-24-081224.md) | Ownership report, active investor, amended | 0001193125-24-081224 |
| 2024-03-25 | 21:48 ET | [SC 13D/A](/filings/0001193125-24-076792.md) | Ownership report, active investor, amended | 0001193125-24-076792 |

Page 1 of 3. [Older](/companies/sprb/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.